Related Experiment Video
Updated: Sep 20, 2026

Manual Segmentation of the Human Choroid Plexus Using Brain MRI
Published on: December 15, 2023
Clinical diagnoses that overlap with choroideremia
Thomas K M Lee1, Kerry E McTaggart, Paul A Sieving
1Department of Ophthalmology, University of Alberta, Edmonton, Alta.
Insights
Clinical features suggesting choroideremia (CHM) include severe chorioretinal atrophy with a preserved macula and X-linked inheritance. Overlapping phenotypes like retinitis pigmentosa (RP), Usher syndrome, and cone-rod dystrophy (CRD) can mimic CHM.
Area of Science:
- Ophthalmology
- Genetics
- Medical Diagnostics
Background:
- Choroideremia (CHM) is an X-linked genetic eye disorder causing progressive vision loss.
- Accurate diagnosis is crucial for genetic counseling and management.
- Clinical presentation can sometimes overlap with other inherited retinal diseases.
Observation:
- A retrospective chart review was conducted on patients with a suspected clinical diagnosis of CHM.
- Cases where laboratory confirmation (protein analysis or gene sequencing) was negative were further analyzed.
- Clinical features, family history, and fundus photographs were reviewed for diagnostic clues.
Findings:
- Of 26 families with a suspected CHM diagnosis not confirmed by lab tests, 13 provided sufficient clinical data.
- Four patients were reclassified as having retinitis pigmentosa (RP), two with clear X-linked inheritance.
- Other reclassifications included a syndrome with macular dystrophy, hearing loss, and developmental delay; congenital stationary night blindness; Usher syndrome; and cone-rod dystrophy (CRD).
Implications:
- Phenotypic overlap exists between CHM and RP, Usher syndrome, and CRD.
- Key diagnostic indicators for CHM include severe chorioretinal atrophy with macular preservation.
- X-linked inheritance patterns and retinal changes in female relatives are significant suggestive features for CHM.
Purpose:
To understand which clinical presentations suggest a diagnosis of choroideremia (CHM).
Methods:
Retrospective chart review. Included were patients for whom a clinical diagnosis of CHM was suggested, but either protein analysis or direct sequencing of the CHM gene could not confirm the diagnosis. Clinical presentation, family history and fundus photographs were reviewed.
Results:
We analyzed protein and DNA samples from members of more than 100 families in which at least 1 member had a clinical diagnosis of CHM. For 26 of these families, the clinical diagnosis of CHM could not be confirmed by laboratory analysis. Relevant clinical information was requested from the referring ophthalmologists so that alternative diagnoses could be considered. Sufficient information was provided for 13 of the 26 families. Four patients were reclassified as having retinitis pigmentosa (RP) from the clinical phenotype; only two clearly had X-linked inheritance. One patient had a syndrome including macular dystrophy, hearing loss, developmental delay and cerebral palsy. One patient was reclassified as having congenital stationary night blindness on the basis of an electronegative electroretinogram and a normal fundus. One patient had hearing loss suggesting Usher syndrome. One patient had signs consistent with cone-rod dystrophy (CRD). Five patients could not be reclassified on the basis of the clinical presentation.
Conclusion:
RP, Usher syndrome and CRD are clinical phenotypes that may overlap with CHM. Clinical features that suggest CHM include severe chorioretinal atrophy with preservation of the macula, X-linked inheritance and retinal changes in a related female.
Related Concept Videos
Photoreceptors and Visual Pathways
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Diabetic Retinopathy
Dementia l: Introduction
Cerebral Edema ll: Pathophysiology
